Dottikon ES Holding AG

BATS-CHIXE:DESNZ Stock Report

Market Cap: CHF 3.1b

Dottikon ES Holding Past Earnings Performance

Past criteria checks 1/6

Dottikon ES Holding has been growing earnings at an average annual rate of 20.2%, while the Pharmaceuticals industry saw earnings declining at 5.2% annually. Revenues have been growing at an average rate of 16% per year. Dottikon ES Holding's return on equity is 8.2%, and it has net margins of 22.4%.

Key information

20.2%

Earnings growth rate

18.0%

EPS growth rate

Pharmaceuticals Industry Growth14.1%
Revenue growth rate16.0%
Return on equity8.2%
Net Margin22.4%
Next Earnings Update28 May 2025

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Dottikon ES Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:DESNZ Revenue, expenses and earnings (CHF Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2433775910
30 Jun 2433578890
31 Mar 2433381870
30 Sep 2334986870
30 Jun 2333787850
31 Mar 2332688840
31 Dec 2230281810
30 Sep 2228474780
30 Jun 2226867770
31 Mar 2225259770
31 Dec 2124057770
30 Sep 2122955770
30 Jun 2122454760
31 Mar 2121952750
31 Dec 2020446730
30 Sep 2018939710
30 Jun 2018236700
31 Mar 2017533690
31 Dec 1917231690
30 Sep 1916930690
30 Jun 1915823680
31 Mar 1914816670
31 Dec 1814717660
30 Sep 1814518650
30 Jun 1815322650
31 Mar 1816126640
31 Dec 1715924600
30 Sep 1715722560
30 Jun 1715622550
31 Mar 1715522530
31 Dec 1615122550
30 Sep 1614823570
30 Jun 1613619550
31 Mar 1612314540
31 Dec 1511310520
30 Sep 151025510
30 Jun 151003500
31 Mar 15981480
31 Dec 14950470
30 Sep 1491-1460
30 Jun 1491-2460
31 Mar 1492-3460

Quality Earnings: DESNZ has a high level of non-cash earnings.

Growing Profit Margin: DESNZ's current net profit margins (22.4%) are lower than last year (24.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DESNZ's earnings have grown significantly by 20.2% per year over the past 5 years.

Accelerating Growth: DESNZ's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: DESNZ had negative earnings growth (-12.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (9.5%).


Return on Equity

High ROE: DESNZ's Return on Equity (8.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 17:15
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dottikon ES Holding AG is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carla BänzigerBank Vontobel AG
Daniel JelovcanZürcher Kantonalbank